Paul T. Martin
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
134
Citations
3,776
Est. group size
—
Recurring co-author estimate
Active years
54
Publishing since 1972
This researcher's work centers on gene therapy approaches for genetic muscle diseases, including muscular dystrophy and GNE myopathy, using viral vectors (particularly AAV) to deliver corrective genes in animal models. Related work also explores glycosylation processes in muscle tissue and lysosomal storage disorders such as lysosomal acid lipase deficiency. Note that the publication list also includes some titles on unrelated topics (e.g., liver disease, lymphoma, psoriatic arthritis), which may reflect co-authorship on collaborative or multi-disciplinary studies rather than a core research focus.
Publication output has been variable over the last decade, with a dip in 2020 followed by fluctuating annual counts and a modest recent pace averaging about 2-3 papers per year.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Synovial immunopathology in psoriatic arthritis: cellular and molecular insights
The Lancet Rheumatology · 2025
- Analysis of Dystrophin-Associated Glycoproteins: Focus on Expression and Glycosylation of Dystroglycan in Skeletal Muscle
Methods in molecular biology · 2025
- 231PSystemic deletion of Gne in adult mice results in thrombocytopenia, anemia, spontaneous bleeding, myopathy and premature death
Neuromuscular Disorders · 2025
- Liver-directed AAV gene therapy normalizes disease symptoms and provides cross-correction in a model of lysosomal acid lipase deficiency
Molecular Therapy · 2024
- Liver-directed AAV gene therapy corrects disease symptoms in a murine model of lysosomal acid lipase deficiency
Molecular Genetics and Metabolism · 2024
- Development of Assays to Measure <i>GNE</i> Gene Potency and Gene Replacement in Skeletal Muscle
Journal of Neuromuscular Diseases · 2023
- P307 Bicistronic FKRP/FST gene therapy fully recovers normal ambulation and induces supranormal muscle strength in the FKRP(P448L) model of limb girdle muscular dystrophy 2I (LGMD2I)
Neuromuscular Disorders · 2023
- P157 Development of a new mouse model to study GNE myopathy
Neuromuscular Disorders · 2023
- Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency
Molecular Therapy — Methods & Clinical Development · 2022
- Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A
Molecular Therapy — Methods & Clinical Development · 2021
- Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength
PLoS ONE · 2021
- rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart
Molecular Therapy · 2019
- Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of <i>GALGT2</i> Expression and <i>GALGT2</i> -Dependent Muscle and Neuromuscular Phenotypes
Molecular and Cellular Biology · 2019
- rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL/6J Mice
Molecular Therapy — Methods & Clinical Development · 2019
- MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA
Hematological Oncology · 2019
- Molecular Therapy — Methods & Clinical Development×5
- Neuromuscular Disorders×5
- Molecular Therapy×3
- American Journal Of Pathology×2
- Human Gene Therapy×2
- Jerry R. Mendell
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Renzhi Han
Biochemistry, Genetics and Molecular Biology · Indiana University
- Louise R. Rodino‐Klapac
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jill A. Rafael‐Fortney
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Noah Weisleder
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile